bTAE-HAIC Combined With Lenvatinib and Sintilimab for Infiltrative Hepatocellular Carcinoma

Conditions: Liver Diseases; Hepatocellular Carcinoma; Immunotherapy; Lenvatinib; Sintilimab Interventions: Procedure: bTAE-HAIC; Drug: Lenvatinib; Drug: Sintilimab Sponsors: Sun Yat-sen University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials